Found: 89
Select item for more details and to access through your institution.
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1021, doi. 10.1007/s10637-022-01287-7
- By:
- Publication type:
- Article
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 614, doi. 10.1007/s10637-022-01223-9
- By:
- Publication type:
- Article
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 410, doi. 10.1007/s10637-019-00782-8
- By:
- Publication type:
- Article
Nursing Students' Use of Recovery Stories of People with Mental Illness in Their Experiences: A Qualitative Study.
- Published in:
- Nursing Reports, 2022, v. 12, n. 3, p. 610, doi. 10.3390/nursrep12030060
- By:
- Publication type:
- Article
An orally administered oral pathobiont and commensal have comparable and innocuous systemic effects in germ‐free mice.
- Published in:
- Journal of Periodontal Research, 2018, v. 53, n. 6, p. 950, doi. 10.1111/jre.12593
- By:
- Publication type:
- Article
Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients.
- Published in:
- Journal of Periodontal Research, 2005, v. 40, n. 1, p. 53, doi. 10.1111/j.1600-0765.2004.00772.x
- By:
- Publication type:
- Article
Brazilian propolis mitigates impaired glucose and lipid metabolism in experimental periodontitis in mice.
- Published in:
- BMC Complementary & Alternative Medicine, 2016, v. 16, p. 1, doi. 10.1186/s12906-016-1305-8
- By:
- Publication type:
- Article
Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 6, p. 633, doi. 10.1007/s40265-019-01113-0
- By:
- Publication type:
- Article
Poncet's Disease (Reactive Arthritis Associated with Tuberculosis).
- Published in:
- Internal Medicine, 2022, v. 61, n. 21, p. 3245, doi. 10.2169/internalmedicine.9241-21
- By:
- Publication type:
- Article
Effects of systemic sitafloxacin on periodontal infection control in elderly patients.
- Published in:
- Gerodontology, 2012, v. 29, n. 2, p. e1024, doi. 10.1111/j.1741-2358.2011.00605.x
- By:
- Publication type:
- Article
Periodontal disease and risk of atherosclerotic coronary heart disease.
- Published in:
- Odontology, 2009, v. 97, n. 2, p. 84, doi. 10.1007/s10266-009-0104-9
- By:
- Publication type:
- Article
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant.
- Published in:
- Immunogenetics, 2012, v. 64, n. 12, p. 869, doi. 10.1007/s00251-012-0646-9
- By:
- Publication type:
- Article
EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 2, p. 499, doi. 10.3892/ijo.2015.3050
- By:
- Publication type:
- Article
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2021, v. 28, n. 1, p. 1, doi. 10.1002/jhbp.868
- By:
- Publication type:
- Article
Reply to L. Celio et al.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
- By:
- Publication type:
- Article
How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-024-10707-8
- By:
- Publication type:
- Article
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 235, doi. 10.1007/s10120-021-01237-x
- By:
- Publication type:
- Article
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
- By:
- Publication type:
- Article
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G).
- Published in:
- Gastric Cancer, 2020, v. 23, n. 4, p. 677, doi. 10.1007/s10120-020-01043-x
- By:
- Publication type:
- Article
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1238, doi. 10.1007/s10120-019-00973-5
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Dose-escalation study for the targeting of CD44v cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205).
- Published in:
- Gastric Cancer, 2017, v. 20, n. 2, p. 341, doi. 10.1007/s10120-016-0610-8
- By:
- Publication type:
- Article
Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 1, p. 54, doi. 10.1007/s10120-013-0238-x
- By:
- Publication type:
- Article
A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2013, v. 16, n. 1, p. 41, doi. 10.1007/s10120-012-0139-4
- By:
- Publication type:
- Article
First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer.
- Published in:
- Gastric Cancer, 2012, v. 15, n. 1, p. 21, doi. 10.1007/s10120-011-0056-y
- By:
- Publication type:
- Article
Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 2, p. 161, doi. 10.1007/s10120-011-0025-5
- By:
- Publication type:
- Article
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 28, doi. 10.1007/s10120-011-0003-y
- By:
- Publication type:
- Article
Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 94, doi. 10.1159/000500326
- By:
- Publication type:
- Article
Phase II Study of Bolus 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer.
- Published in:
- Oncology, 2011, v. 81, n. 5/6, p. 291, doi. 10.1159/000334462
- By:
- Publication type:
- Article
Clinical Significance of Insulin-Like Growth Factor Type 1 Receptor and Epidermal Growth Factor Receptor in Patients with Advanced Gastric Cancer.
- Published in:
- Oncology, 2008, v. 74, n. 1/2, p. 76, doi. 10.1159/000139127
- By:
- Publication type:
- Article
IL-4- and IL-6-producing cells in human periodontal disease tissue.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 1, p. 106, doi. 10.1002/mc.22476
- By:
- Publication type:
- Article
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
- By:
- Publication type:
- Article
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 355, doi. 10.1007/s10147-020-01802-x
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 1, doi. 10.1007/s10147-017-1101-6
- By:
- Publication type:
- Article
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 6, p. 1020, doi. 10.1007/s10147-012-0478-5
- By:
- Publication type:
- Article
Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial.
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 6, p. 604, doi. 10.1007/s10147-011-0331-2
- By:
- Publication type:
- Article
Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 1, p. 57, doi. 10.1007/s10147-010-0135-9
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
Clinical Trial Results. A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese PatientsWithMetastatic Colorectal Cancer (BIX Study)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Clinical Trial Results. A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese PatientsWithMetastatic Colorectal Cancer (BIX Study).
- Published in:
- Oncologist, 2014, v. 19, n. 11, p. 1130, doi. 10.1634/theoncologist.2014-0159
- By:
- Publication type:
- Article
Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease.
- Published in:
- Journal of Periodontal Research, 1993, v. 28, n. 5, p. 324, doi. 10.1111/j.1600-0765.1993.tb01076.x
- By:
- Publication type:
- Article
Chronic Oral Infection with Porphyromonas gingivalis Accelerates Atheroma Formation by Shifting the Lipid Profile.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020240
- By:
- Publication type:
- Article
Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice.
- Published in:
- Lipids in Health & Disease, 2012, v. 11, n. 1, p. 121, doi. 10.1186/1476-511X-11-121
- By:
- Publication type:
- Article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article